We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Wholesaler Sues Sanofi-Aventis Over Arthritis Drug

Law360 (August 21, 2007, 12:00 AM EDT) -- A drug wholesaler has sought treble damages in a putative class action lawsuit against Sanofi-Aventis, accusing the French pharmaceutical giant of unlawfully blocking generic competition for Sanofi's rheumatoid arthritis treatment Arava by filing a sham Citizen Petition with the U.S. Food and Drug Administration.

Louisiana Wholesale Drug Co. Inc. filed the lawsuit on Friday in federal court in Manhattan, against Sanofi-Aventis, Sanofi-Aventis US LLC and Aventis Pharmaceuticals Inc.

The drug at issue in the suit is leflunomide, which is sold under the brand name Arava. AB-rated...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.